{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T17:23:51Z","timestamp":1751736231917},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00292-020-00800-0","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T13:02:36Z","timestamp":1591966956000},"page":"434-443","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen Fettlebererkrankung"],"prefix":"10.1007","volume":"41","author":[{"given":"Sarah","family":"Theurer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"K\u00e4lsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Schwertheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Kathemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo A.","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"issue":"30","key":"800_CR1","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","volume":"24","author":"S Leoni","year":"2018","unstructured":"Leoni\u00a0S et al (2018) Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis. World J Gastroenterol 24(30):3361\u20133373","journal-title":"World J Gastroenterol"},{"key":"800_CR2","volume-title":"Practical hepatic pathology\u2014a diagnostic approach. Nonalcoholic fatty liver disease. Vol. 1","author":"R Saxena","year":"2011","unstructured":"Saxena\u00a0R, Yeh\u00a0M (2011) Practical hepatic pathology\u2014a diagnostic approach. Nonalcoholic fatty liver disease. Vol. 1 Bd. 1. Elsevier, Philadelphia"},{"issue":"7","key":"800_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1055\/s-0035-1553193","volume":"53","author":"E Roeb","year":"2015","unstructured":"Roeb\u00a0E et al (2015) S2k guideline non-alcoholic fatty liver disease. Z\u00a0Gastroenterol 53(7):668\u2013723","journal-title":"Z Gastroenterol"},{"issue":"3","key":"800_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00292-010-1274-5","volume":"31","author":"A Tannapfel","year":"2010","unstructured":"Tannapfel\u00a0A et al (2010) Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Grade 2 consensus-based guidelines. Pathologe 31(3):225\u2013237","journal-title":"Pathologe"},{"issue":"5","key":"800_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00428-011-1066-1","volume":"458","author":"A Tannapfel","year":"2011","unstructured":"Tannapfel\u00a0A et al (2011) Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease. Virchows Arch 458(5):511\u2013523","journal-title":"Virchows Arch"},{"issue":"1","key":"800_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani\u00a0N et\u00a0al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328\u2013357","journal-title":"Hepatology"},{"issue":"22","key":"800_CR7","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella\u00a0ME (2015) Nonalcoholic fatty liver disease: a\u00a0systematic review. JAMA 313(22):2263\u20132273","journal-title":"JAMA"},{"issue":"2","key":"800_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000323886","volume":"29","author":"F Scaglioni","year":"2011","unstructured":"Scaglioni\u00a0F et\u00a0al (2011) ASH and NASH. Dig Dis 29(2):202\u2013210","journal-title":"Dig Dis"},{"key":"800_CR9","doi-asserted-by":"publisher","first-page":"13058","DOI":"10.1038\/srep13058","volume":"5","author":"J Kalsch","year":"2015","unstructured":"Kalsch\u00a0J et\u00a0al (2015) Normal liver enzymes are correlated with severity of metabolic syndrome in a\u00a0large population based cohort. Sci Rep 5:13058","journal-title":"Sci Rep"},{"issue":"2","key":"800_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00428-013-1512-3","volume":"464","author":"H Reis","year":"2014","unstructured":"Reis\u00a0H et al (2014) Oil Red O\u2011assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome. Virchows Arch 464(2):165\u2013174","journal-title":"Virchows Arch"},{"issue":"8","key":"800_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","volume":"65","author":"GT Brown","year":"2016","unstructured":"Brown\u00a0GT, Kleiner\u00a0DE (2016) Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism 65(8):1080\u20131086","journal-title":"Metabolism"},{"issue":"1","key":"800_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal\u00a0AJ et\u00a0al (2011) Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 54(1):344\u2013353","journal-title":"Hepatology"},{"issue":"5","key":"800_CR13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa\u00a0P et\u00a0al (2012) Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56(5):1751\u20131759","journal-title":"Hepatology"},{"issue":"5","key":"800_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jhep.2019.12.008","volume":"72","author":"F Nascimbeni","year":"2020","unstructured":"Nascimbeni\u00a0F et al (2020) Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease. J\u00a0Hepatol 72(5):828\u2013838","journal-title":"J Hepatol"},{"key":"800_CR15","doi-asserted-by":"crossref","unstructured":"Schwertheim\u00a0SK, Jastrow\u00a0H, Schaefer\u00a0CM, Theurer\u00a0S, Ting\u00a0S, Canbay\u00a0A, Wedemeyer\u00a0H, Schmid\u00a0KW, Baba\u00a0HA (2020) Characterization of two types of intranuclear hepatocellular inclusions in NAFLD. submitted","DOI":"10.20517\/2394-5079.2020.23"},{"issue":"3","key":"800_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt\u00a0EM et\u00a0al (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53(3):810\u2013820","journal-title":"Hepatology"},{"issue":"2","key":"800_CR17","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/hep.27173","volume":"60","author":"P Bedossa","year":"2014","unstructured":"Bedossa\u00a0P, Consortium\u00a0FP (2014) Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Hepatology 60(2):565\u2013575","journal-title":"Hepatology"},{"issue":"2","key":"800_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/lt.24964","volume":"24","author":"E Nicastro","year":"2018","unstructured":"Nicastro\u00a0E, D\u2019Antiga\u00a0L (2018) Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl 24(2):282\u2013293","journal-title":"Liver Transpl"},{"issue":"2","key":"800_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000443344","volume":"9","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity (2016) EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes Facts 9(2):65\u201390","journal-title":"Obes Facts"},{"issue":"4","key":"800_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00292-012-1735-0","volume":"34","author":"D Goltz","year":"2013","unstructured":"Goltz\u00a0D et al (2013) Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction. Pathologe 34(4):318\u2013322","journal-title":"Pathologe"},{"issue":"3","key":"800_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00292-017-0400-z","volume":"39","author":"S Synoracki","year":"2018","unstructured":"Synoracki\u00a0S et al (2018) Lysosomal acid lipase deficiency (LAL-D): diagnostic and therapeutic options in an underdiagnosed disease. Pathologe 39(3):249\u2013254","journal-title":"Pathologe"},{"issue":"10215","key":"800_CR22","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi\u00a0ZM et al (2019) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a\u00a0multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394(10215):2184\u20132196","journal-title":"Lancet"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-020-00800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T23:20:17Z","timestamp":1623453617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-020-00800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00800-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"12 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Theurer, J.\u00a0K\u00e4lsch, S.\u00a0Schwertheim, S.\u00a0Kathemann und H.\u00a0A.\u00a0Baba geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}